Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | PAM | P19021 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27912109 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL17540714 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL2698556 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL17540715 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL17950790 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL633425 | 0.90 | — | — | |
| SCHEMBL5176784 | 0.90 | — | — | |
| SCHEMBL4212865 | 0.84 | ALDH1A1 (0.38) | ALDH1A1CYP2D6ALOX15 | |
| SCHEMBL4970454 | 0.84 | CYP2D6 (0.73) | ALDH1A1CYP2D6ALOX15PAMLMNA | |
| SCHEMBL4078133 | 0.84 | CYP2D6 (0.73) | ALDH1A1CYP2D6ALOX15PAMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2605654-B1 | EPIPYRONE A AS AN ANTI-MICROBIAL AGENT | BIOTELLIGA HOLDINGS LTD (NZ) | 2023-09-27 | — | — | EP | disclosed |
| US-20160021881-A1 | ANTI-MICROBIAL COMPOSITIONS | BIOTELLIGA HOLDINGS LTD (NZ) | 2016-01-28 | — | — | US | disclosed |
| US-20140357580-A1 | ANTI-MICROBIAL COMPOSITIONS | BIOTELLIGA HOLDINGS LTD (NZ) | 2014-12-04 | — | — | US | disclosed |
| US-8889636-B2 | Anti-microbial compositions | BIOTELLIGA HOLDINGS LIMITED (NZ) | 2014-11-18 | — | — | US | disclosed |
| US-20120108526-A1 | ANTI-MICROBIAL COMPOSITIONS | BIOTELLIGA HOLDINGS LIMITED (NZ) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108526-A1 | ANTI-MICROBIAL COMPOSITIONS | SYMPK, GALE, GNE | ALDH1A1 3358/4885CYP2D6 1165/4885ALOX15 901/4885 |
| US-20140357580-A1 | ANTI-MICROBIAL COMPOSITIONS | SYMPK, PGLS, GALE | ALDH1A1 3103/4885CYP2D6 506/4885ALOX15 1007/4885 |
| US-20160021881-A1 | ANTI-MICROBIAL COMPOSITIONS | SYMPK, PGLS, GALE | ALDH1A1 3103/4885CYP2D6 506/4885ALOX15 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.